Pic: Getty
Check up: Making it in America
Health & Biotech
share
Here’s our fortnightly wrap of all the news driving ASX health stocks.
Of the ASX’s 137-odd small cap health stocks and of those which were trading on Tuesday, 66 were in positive territory over the last fortnight, 18 were flat and 47 saw their share prices fall.
| Code | Name | Price $ (May 27) | 2 week return % | 1 year return % | Market cap |
|---|---|---|---|---|---|
| IPD | IMPEDIMED LTD | 0.08 | 107 | -52 | $85,144,264 |
| ATX | AMPLIA THERAPEUTICS LTD | 0.14 | 63 | 17 | $9,304,846 |
| ANP | ANTISENSE THERAPEUTICS LTD | 0.073 | 61 | 45 | $36,170,112 |
| OSP | OSPREY MEDICAL INC-CDI | 0.018 | 60 | -86 | $20,568,652 |
| RCE | RECCE PHARMACEUTICALS LTD | 0.735 | 60 | 245 | $103,414,560 |
| 1AD | ADALTA LTD | 0.087 | 42 | -61 | $13,935,377 |
| LBT | LBT INNOVATIONS LTD | 0.16 | 39 | -18 | $37,686,364 |
| VBS | VECTUS BIOSYSTEMS LTD | 0.68 | 39 | 64 | $16,085,275 |
| IBX | IMAGION BIOSYSTEMS LTD | 0.029 | 33 | 30 | $21,324,244 |
| NOX | NOXOPHARM LTD | 0.23 | 31 | -58 | $40,051,256 |
| IDT | IDT AUSTRALIA LTD | 0.19 | 28 | 0 | $44,272,912 |
| BOT | BOTANIX PHARMACEUTICALS LTD | 0.054 | 26 | -52 | $51,552,996 |
| CAJ | CAPITOL HEALTH LTD | 0.225 | 25 | -3 | $230,084,368 |
| ESE | ESENSE-LAB LTD-CDI | 0.01 | 25 | -47 | $1,900,769 |
| BNO | BIONOMICS LTD | 0.0545 | 21 | -58 | $29,685,380 |
| CAN | CANN GROUP LTD | 1.155 | 21 | -45 | $173,931,824 |
| PYC | PYC THERAPEUTICS LTD | 0.088 | 21 | 267 | $257,965,664 |
| M7T | MACH7 TECHNOLOGIES LTD | 0.72 | 20 | 114 | $127,117,216 |
| PCK | PAINCHEK LTD | 0.18 | 19 | 42 | $191,571,648 |
| HLA | HEALTHIA LTD | 1.03 | 18 | 17 | $64,925,692 |
| FTT | FACTOR THERAPEUTICS LTD | 0.0035 | 17 | -42 | $3,649,925 |
| GTG | GENETIC TECHNOLOGIES LTD | 0.006 | 17 | 7 | $35,796,460 |
| PAL | PALLA PHARMA LTD | 0.8 | 16 | -28 | $100,758,384 |
| UBI | UNIVERSAL BIOSENSORS INC-CDI | 0.225 | 15 | 10 | $39,928,360 |
| THC | THC GLOBAL GROUP LTD | 0.385 | 15 | -14 | $53,492,424 |
| S66 | STAR COMBO PHARMA LTD | 0.55 | 15 | -28 | $40,672,204 |
| MMJ | MMJ GROUP HOLDINGS LTD | 0.13 | 13 | -45 | $29,894,018 |
| RSH | RESPIRI LTD | 0.073 | 13 | -51 | $45,681,416 |
| MDR | MEDADVISOR LTD | 0.59 | 12 | 47 | $146,778,816 |
| IHL | IMPRESSION HEALTHCARE LTD | 0.056 | 12 | 180 | $40,847,292 |
| PTX | PRESCIENT THERAPEUTICS LTD | 0.05 | 11 | 20 | $19,318,770 |
| ATH | ALTERITY THERAPEUTICS LTD | 0.018 | 11 | -46 | $20,747,160 |
| IMU | IMUGENE LTD | 0.032 | 10 | 78 | $141,631,056 |
| OVN | OVENTUS MEDICAL LTD | 0.275 | 10 | 11 | $41,123,536 |
| MVP | MEDICAL DEVELOPMENTS INTERNA | 8.1 | 9 | 57 | $541,393,792 |
| VHT | VOLPARA HEALTH TECHNOLOGIES | 1.435 | 9 | -19 | $363,003,328 |
| RHT | RESONANCE HEALTH LTD | 0.185 | 9 | 58 | $84,317,048 |
| RGS | REGENEUS LTD | 0.081 | 9 | -26 | $21,114,700 |
| PNV | POLYNOVO LTD | 2.64 | 8 | 133 | $1,784,937,728 |
| PAB | PATRYS LTD | 0.013 | 8 | -50 | $13,943,674 |
| LCT | LIVING CELL TECHNOLOGIES LTD | 0.013 | 8 | -57 | $7,428,733 |
| DXB | DIMERIX LTD | 0.28 | 8 | 260 | $49,012,212 |
| ADR | ADHERIUM LTD | 0.027 | 8 | -15 | $13,917,236 |
| MX1 | MICRO-X LTD | 0.145 | 7 | -48 | $51,789,336 |
| SDX | SIENNA CANCER DIAGNOSTICS LT | 0.062 | 7 | 13 | $24,498,236 |
| CP1 | CANNPAL ANIMAL THERAPEUTICS | 0.093 | 7 | -41 | $8,753,750 |
| ZLD | ZELIRA THERAPEUTICS LTD | 0.048 | 7 | 7 | $46,681,364 |
| IMM | IMMUTEP LTD | 0.18 | 7 | -42 | $78,020,952 |
| PAR | PARADIGM BIOPHARMACEUTICALS | 2.58 | 6 | 78 | $593,306,176 |
| CTE | CRYOSITE LTD | 0.085 | 6 | 89 | $3,983,063 |
| NC6 | NANOLLOSE LTD | 0.035 | 6 | -32 | $3,701,250 |
| BWX | BWX LTD | 3.79 | 6 | 139 | $472,149,568 |
| KZA | KAZIA THERAPEUTICS LTD | 0.415 | 5 | -5 | $39,258,324 |
| ZNO | ZOONO GROUP LTD | 1.86 | 5 | 1069 | $305,768,768 |
| AMT | ALLEGRA ORTHOPAEDICS LTD | 0.115 | 5 | 15 | $11,449,291 |
| ADO | ANTEOTECH LTD | 0.023 | 5 | 57 | $37,813,928 |
| BD1 | BARD1 LIFE SCIENCES LTD | 0.028 | 4 | 36 | $36,913,996 |
| TD1 | TALI DIGITAL LTD | 0.031 | 3 | 72 | $23,228,462 |
| CYC | CYCLOPHARM LTD | 1.65 | 3 | -2 | $112,547,720 |
| CGS | COGSTATE LTD | 0.32 | 3 | 35 | $54,446,452 |
| ONT | 1300 SMILES LTD | 5.31 | 3 | -13 | $125,732,216 |
| OPT | OPTHEA LTD | 2.95 | 3 | 360 | $804,781,760 |
| PIQ | PROTEOMICS INTERNATIONAL LAB | 0.36 | 3 | 12 | $33,536,520 |
| PXS | PHARMAXIS LTD | 0.091 | 2 | -68 | $35,967,676 |
| PBP | PROBIOTEC LTD | 1.965 | 2 | 25 | $145,818,800 |
| AVH | AVITA MEDICAL LTD | 0.455 | 1 | 2 | $992,047,232 |
| AVE | AVECHO BIOTECHNOLOGY LTD | 0.007 | 0 | 133 | $11,182,202 |
| ELX | ELLEX MEDICAL LASERS LTD | 0.5 | 0 | -15 | $71,800,568 |
| IVX | INVION LTD | 0.009 | 0 | -43 | $44,004,852 |
| BXN | BIOXYNE LTD | 0.014 | 0 | -26 | $8,962,036 |
| CDX | CARDIEX LTD | 0.022 | 0 | -28 | $17,323,814 |
| AC8 | AUSCANN GROUP HOLDINGS LTD | 0.17 | 0 | -55 | $53,898,052 |
| ALT | ANALYTICA LTD | 0.003 | 0 | -40 | $10,558,837 |
| BIT | BIOTRON LTD | 0.094 | 0 | 24 | $65,279,744 |
| APH | AUSTRALIAN PRIMARY HEMP LTD | 0.13 | 0 | -41 | $9,068,168 |
| MEM | MEMPHASYS LTD | 0.068 | 0 | 164 | $49,762,276 |
| NSB | NEUROSCIENTIFIC BIOPHARMACEU | 0.175 | 0 | 17 | $13,717,302 |
| ACR | ACRUX LTD | 0.135 | 0 | -31 | $22,752,700 |
| GSS | GENETIC SIGNATURES LTD | 1.985 | 0 | 78 | $279,517,568 |
| MEB | MEDIBIO LTD | 0.007 | 0 | -36 | $6,965,911 |
| NTI | NEUROTECH INTERNATIONAL LTD | 0.006 | 0 | -45 | $1,291,294 |
| LSH | LIFESPOT HEALTH LTD | 0.033 | 0 | -60 | $2,630,920 |
| VTI | VISIONEERING TECH-CDI | 0.016 | 0 | -74 | $7,452,829 |
| FFC | FARMAFORCE LTD | 0.08 | 0 | -30 | $10,301,678 |
| SDI | SDI LTD | 0.755 | -1 | -16 | $89,743,472 |
| ICS | ICSGLOBAL LTD | 1.85 | -1 | 91 | $19,140,254 |
| MVF | MONASH IVF GROUP LTD | 0.565 | -1 | -45 | $204,982,784 |
| RHY | RHYTHM BIOSCIENCES LTD | 0.099 | -1 | -45 | $9,369,750 |
| IMC | IMMURON LTD | 0.084 | -1 | -56 | $14,886,346 |
| AGH | ALTHEA GROUP HOLDINGS LTD | 0.38 | -1 | -42 | $89,824,352 |
| RNO | RHINOMED LTD | 0.073 | -1 | -74 | $12,267,436 |
| UCM | USCOM LTD | 0.215 | -2 | 30 | $32,176,708 |
| PSQ | PACIFIC SMILES GROUP LTD | 1.4 | -2 | 18 | $214,921,776 |
| RAP | RESAPP HEALTH LTD | 0.17 | -3 | 13 | $124,970,312 |
| HCT | HOLISTA COLLTECH LTD | 0.165 | -3 | 150 | $46,809,344 |
| NYR | NYRADA INC-CDI | 0.155 | -3 | -22 | $18,048,314 |
| 1ST | 1ST GROUP LTD | 0.029 | -3 | -40 | $12,313,890 |
| GLH | GLOBAL HEALTH LTD | 0.14 | -3 | 7 | $5,893,765 |
| NEU | NEUREN PHARMACEUTICALS LTD | 1.675 | -3 | 33 | $173,325,632 |
| MXC | MGC PHARMACEUTICALS LTD | 0.025 | -4 | -55 | $39,390,308 |
| TLX | TELIX PHARMACEUTICALS LTD | 1.355 | -4 | 55 | $357,638,944 |
| CPH | CRESO PHARMA LTD | 0.068 | -4 | -85 | $15,274,289 |
| AHX | APIAM ANIMAL HEALTH LTD | 0.44 | -4 | 3 | $52,468,712 |
| CYP | CYNATA THERAPEUTICS LTD | 0.69 | -4 | -44 | $72,962,656 |
| AZV | AZURE HEALTHCARE LTD | 0.067 | -4 | -15 | $19,040,660 |
| JHC | JAPARA HEALTHCARE LTD | 0.56 | -4 | -58 | $148,322,272 |
| VLS | VITA LIFE SCIENCES LTD | 0.57 | -4 | -20 | $29,204,610 |
| MDC | MEDLAB CLINICAL LTD | 0.21 | -4 | -46 | $50,142,688 |
| OIL | OPTISCAN IMAGING LTD | 0.043 | -4 | 8 | $20,544,488 |
| OSX | OSTEOPORE LTD | 0.495 | -5 | 148 | $50,109,100 |
| NXS | NEXT SCIENCE LTD | 1.55 | -5 | -44 | $280,389,856 |
| ALC | ALCIDION GROUP LTD | 0.16 | -6 | 63 | $148,604,112 |
| SOM | SOMNOMED LTD | 1.09 | -6 | -32 | $83,832,592 |
| SKN | SKIN ELEMENTS LTD | 0.08 | -7 | 82 | $25,411,448 |
| EXL | ELIXINOL GLOBAL LTD | 0.275 | -8 | -94 | $50,276,272 |
| RAC | RACE ONCOLOGY LTD | 0.33 | -9 | 400 | $36,989,588 |
| OSL | ONCOSIL MEDICAL LTD | 0.105 | -9 | 60 | $82,293,168 |
| SVA | SIMAVITA LTD-CDI | 0.02 | -9 | 18 | $11,275,563 |
| CMP | COMPUMEDICS LTD | 0.51 | -10 | -13 | $87,695,656 |
| ACW | ACTINOGEN MEDICAL LTD | 0.018 | -10 | 50 | $20,092,164 |
| ANR | ANATARA LIFESCIENCES LTD | 0.175 | -10 | -54 | $8,724,831 |
| ONE | ONEVIEW HEALTHCARE PLC-CDI | 0.047 | -11 | -81 | $8,140,940 |
| DVL | DORSAVI LTD | 0.023 | -12 | -63 | $5,322,833 |
| JHL | JAYEX HEALTHCARE LTD | 0.022 | -12 | -35 | $3,879,987 |
| GMV | G MEDICAL INNOVATION HOLDING | 0.069 | -13 | -71 | $45,801,272 |
| PAA | PHARMAUST LTD | 0.099 | -13 | 146 | $28,994,022 |
| PGC | PARAGON CARE LTD | 0.17 | -13 | -61 | $57,440,500 |
| SUD | SUDA PHARMACEUTICALS LTD | 0.043 | -14 | -74 | $6,116,939 |
| OCC | ORTHOCELL LTD | 0.33 | -14 | -33 | $60,950,580 |
| SCU | STEMCELL UNITED LTD | 0.011 | -15 | -31 | $7,057,692 |
| CDY | CELLMID LTD | 0.185 | -18 | -5 | $22,329,762 |
| BPH | BPH ENERGY LTD | 0.008 | -20 | -20 | $2,985,795 |
Body fluid monitor Impedimed (ASX:IPD) was the surprise flier this week after the stock more than doubled for no observable reason from May 20.
Over five days the stock shot up from 4c to 9c.
The company claimed innocence, saying “we have no explanation for the increase in share price and volume”.
But as often happens with ASX speeding tickets Impedimed did get a plug in for the business: “we do note that each of the analysts that cover the company, Canaccord Genuity, Wilsons HTM Equities Research and Morgans Financial, have recent price targets in excess of currently traded prices.”
Impedimed has been trying to make a living in the US for years, and may have finally cracked that nut according to Morgans Financial analyst Scott Power.
Amplia Therapeutics (ASX: ATX) received a second Orphan Drug Designation in the US for its idiopathic pulmonary fibrosis treatment.
The designation, for drugs seeking to treat rare diseases, means Amplia will qualify for waived US Food and Drug Administration fees, clinical trial protocol assistance and other incentives including around market exclusivity if the drug makes it that far.
‘Idiopathic’ refers to a condition which appears with no known cause. Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred.
Antisense Therapeutics (ASX:ANP) surged following final phase two clinical trial results for its immunomodulatory therapy, ATL1102 for Duchenne Muscular Dystrophy (DMD), that met primary and secondary endpoints.
The key outcome in the nine-boy trial was that it was safe and worked. The secondary outcomes met included functional capacity around grip and pinch strength. MRI assessments of upper limb muscles showed the drug appeared to stabilise the fat fraction percentage in the muscles of the forearm.
DMD is a debilitating disease that affects one in every 3500 to 5000 boys and causes muscles to deteriorate and breakdown.
Patients are wheelchair-bound by the time they reach eight to 11 years and many do not survive past their 20s.
Imagion (ASX:IBX) did a deal with Siemens to further develop protocols around putting its cancer-detecting nanoparticles into the body and the share price shot up.
Cancer biotech Noxopharm (ASX:NOX) fell just outside the top 10 movers but inside the top five that had any news to back a share price movement.
The company lodged a pre-Investigational New Drug (pre-IND) submission for a clinical trial of its cancer treatment in patients with COVID-19.
It reckons it has an active ingredient in its drug, idronoxil, that inhibits an inflammatory pathway when the body goes into overdrive against COVID-19.
A pre-IND is an ‘introduction’ to the regulator, which can then decide whether to allow further studies go ahead.
IDT Australia (ASX:IDT) has finally seen some cannabis action.
Cann Group (ASX:CAN), for which it manufactures marijuana medications, said this week it signed and started two new export supply agreements with European and UK companies to supply medicinal cannabis formulated oil and dried flower products.
With cannabis and cannabis related stocks still wallowing in Australia (despite upward moves overseas), the news was a welcome change from the usual never-completed partnership MoU fluff common in the sector.
Explore More
Read MoreHealth
